Molecule Details
| InChIKey | ZXEIEKDGPVTZLD-NDEPHWFRSA-N |
|---|---|
| Compound Name | Eflucimibe |
| Canonical SMILES | CCCCCCCCCCCCS[C@H](C(=O)Nc1cc(C)c(O)c(C)c1C)c1ccccc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.2 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB19825 |
|---|---|
| Drug Name | Eflucimibe |
| CAS Number | 202340-45-2 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Eflucimibe is a small molecule drug. Eflucimibe has a monoisotopic molecular weight of 469.3 Da. |
Categories: Amides Amines Aniline Compounds Anticholesteremic Agents
Cross-references: BindingDB: 182848 CHEMBL1908306 ZINC: ZINC000008214712
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P23141 | CES1 | Liver carboxylesterase 1 | inhibitor | targets |